PharmaceuticalCompanies
List your company
CompaniesCDMOsAPIGeographyShortagesPatent cliff
Register entry

Tris Pharma, Inc.

Request a quoteClaim this profile
Registered sites
2
Drug products
20
Live patents
32
Countries
1
Base
United States
Authorisation

Registered operations

What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.

Analytical testingLabellingFinished drug manufacturePackaging
Sites

Facilities

2
SiteLocationOperationsFEI
Tris Pharma, Inc.Cranbury, NJUnited StatesFinished drug manufacture3008079002
Tris Pharma IncMonmouth Junction, NJUnited StatesAnalytical testing, Labelling, Finished drug manufacture, Packaging3004712471
Exclusivity

Patents

32

Unexpired Orange Book patents where this company is the application holder.

ProductActive ingredientExpiry
DYANAVEL XRAMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATEMar 2027
DYANAVEL XRAMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATEMar 2029
DYANAVEL XRAMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATESept 2036
DYANAVEL XR 10AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATEMar 2027
DYANAVEL XR 10AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATESept 2038
DYANAVEL XR 10AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATEFeb 2040
DYANAVEL XR 15AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATEMar 2027
DYANAVEL XR 15AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATESept 2038
DYANAVEL XR 15AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATEFeb 2040
DYANAVEL XR 20AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATEMar 2027
DYANAVEL XR 20AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATESept 2038
DYANAVEL XR 20AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATEFeb 2040
DYANAVEL XR 5AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATEMar 2027
DYANAVEL XR 5AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATESept 2038
DYANAVEL XR 5AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATEFeb 2040
ONYDA XRCLONIDINE HYDROCHLORIDEMar 2029
ONYDA XRCLONIDINE HYDROCHLORIDEJul 2041
TUZISTRA XRCHLORPHENIRAMINE POLISTIREX; CODEINE POLISTIREXMar 2027
TUZISTRA XRCHLORPHENIRAMINE POLISTIREX; CODEINE POLISTIREXMar 2029
Catalogue

Marketed products

20

Showing 20 of 20.

BrandGeneric nameFormCategory
Cyproheptadine HydrochlorideCyproheptadine HydrochlorideSYRUPANDA
FebuxostatfebuxostatTABLETANDA
FebuxostatfebuxostatTABLETANDA
LacosamideLacosamideTABLETANDA
LacosamideLacosamideTABLETANDA
LacosamideLacosamideTABLETANDA
LacosamideLacosamideTABLETANDA
PaliperidonepaliperidoneTABLET, EXTENDED RELEASEANDA
PaliperidonepaliperidoneTABLET, EXTENDED RELEASEANDA
PaliperidonepaliperidoneTABLET, EXTENDED RELEASEANDA
PaliperidonepaliperidoneTABLET, EXTENDED RELEASEANDA
Potassium ChloridePotassium ChlorideSOLUTIONANDA
Potassium ChloridePotassium ChlorideSOLUTIONANDA
PregabalinPregabalinCAPSULEANDA
PregabalinPregabalinCAPSULEANDA
PregabalinPregabalinCAPSULEANDA
PregabalinPregabalinCAPSULEANDA
PregabalinPregabalinCAPSULEANDA
PregabalinPregabalinCAPSULEANDA
PregabalinPregabalinCAPSULEANDA
Provenance

Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.